Bone Replacement Market by Product Type (Hip, Knee, and Extremities), Material (Allografts, Autografts, Synthetic Materials, and Bone Morphogenetic Proteins (BMPs), and Age Group (<45 Years, 45-64 Years, and 65+ Years): Global Opportunity Analysis and Industry Forecast, 2021–2030
- ALL4676945
- 237 Pages
- September 2021
- Diagnostic and Biotech
Bone replacement is a surgical procedure that replaces missing bone in order to repair bone fractures that are very complex, pose a significant health risk to the patient, or fail to heal properly. The bone replacement procedure makes use of grafts, synthetic materials, and other biologics. Furthermore, some small or acute fractures can be cured without bone replacement, but the risk is greater for large fractures like complex fractures. Bone generally has the ability to regenerate completely but requires a very small fracture space or some sort of scaffold to do so.
The factors that drive the growth of bone replacement market are rise in number of road accidents (minimum more than 1.25 million each year), growth in geriatric population, and technological advancements in bone graft devices. Furthermore, increasing rates of patients associated with family history of osteoporosis will stimulate growth of bone replacement business. However, high cost of bone replacement surgeries and ethical issues related to bone grafting procedures act as major restraints of the market. Presence of large patient pool and increase in medical needs provide lucrative opportunities for the growth of the market. According to the WHO, the geriatric population in the developing countries is projected to increase by 250% between 2010 and 2050 as compared to 71% in the developed countries. This is expected to increase the patient population in these regions, thereby fueling the market growth.
Knee replacement segment will grow at immense pace over the forecast period, owing to increase in prevalence of arthritis coupled with increasing knee injuries will boost demand for knee replacement segment. Additionally, growing geriatric population will further propel knee replacement surgeries, thus propels the market growth.
Based on material, the allografts segment is anticipated to become the fastest-growing segment during the forecast duration. Currently, there is an increase in the demand for allografts primarily due to their exclusive characteristics such as they help reduce pain, restore mobility and may also help patients regain their normal functions. Allograft differs from autografts in a manner that these are derived from an individual other than the recipient of the graft. These can also be used as a substitute to autograft, as these exhibit higher osteoconductive properties.
North America is projected to account for a major share of the global bone replacement market during the forecast period. The market in the region is anticipated grow in future, owing to presence of large portion of geriatric population. According to U.S. Census Bureau, U.S. possess a huge population around 47.8 million with age above 60 years and the number is projected to reach 98.2 million by 2060. Geriatric population is more prone towards bone disorders, leading to higher demand of bone replacement surgery resulting in lucrative business growth opportunity in the future.
The global bone replacement market is segmented on the basis of product type, material, age group, and region. Based on type, the market is categorized into hip, knee, and extremities. The hip segment is further divided into fixed bearing implants, hybrid total hip implants, mobile bearing total hip implants, and total hip implant fixation (cemented or cementless). The knee segment is bifurcated into partial knee replacement (PKR) and total knee replacement (TKR). The extremities segment is classified into upper extremities (shoulder, elbow, hand & wrist replacement) and lower extremities (foot and ankle replacements). In terms of material, the market is divided into allografts, autografts, synthetic materials, and bone morphogenic proteins (BMPs). By age group, it is classified into <45 years, 45-64 years, and 65+ years. Region-wise the market is studied across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the global bone replacement market along with the current trends and future estimations to elucidate the imminent investment pockets.
• A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
• Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of the key segments of the industry helps understand the applications and applications of mother & child healthcare used across the globe.
• Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
• Product Type
o Hip
Fixed Bearing Implants
Hybrid Total Hip Implants
Mobile Bearing Total Hip Implants
Total Hip Implant Fixation
o Knee
Total Knee Replacement
Partial Knee Replacement
o Extremities
Upper Extremities
Lower Extremities
• By Material
o Allografts
o Autografts
o Synthetic Materials
o Bone Morphogenic Proteins (BMPs)
• By Age Group
o < 45
o 45-64 Years
o 65 + Years
• By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o Australia
o India
o South Korea
o Rest of Asia-Pacific
• LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Rise in incidence of musculoskeletal conditions
3.5.1.2.Increase in number of road accidents
3.5.2.Restraints
3.5.2.1.High cost of bone replacement surgeries
3.5.2.2.Ethical issues related with bone grafting procedures
3.5.3.Opportunity
3.5.3.1.Emerging markets to offer lucrative growth opportunities
3.5.4.Impact analysis
3.6.COVID-19 impact analysis on the bone replacement market
CHAPTER 4:BONE REPLACEMENT MARKET, BY PRODUCT TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Hip
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Market size and forecast, by type
4.2.4.1.Fixed bearing implants
4.2.4.1.1.Market size and forecast
4.2.4.2.Hybrid total hip implants
4.2.4.2.1.Market size and forecast
4.2.4.3.Mobile bearing total hip implants
4.2.4.3.1.Market size and forecast
4.2.4.4.Total hip implant fixation
4.2.4.4.1.Market size and forecast
4.3.Knee
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.3.4.Market size and forecast, by type
4.3.4.1.Total knee replacement
4.3.4.1.1.Market size and forecast
4.3.4.2.Partial knee replacement
4.3.4.2.1.Market size and forecast
4.4.Extremities
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
4.4.4.Market size and forecast, by type
4.4.4.1.Upper extremities
4.4.4.1.1.Market size and forecast
4.4.4.2.Lower extremities
4.4.4.2.1.Market size and forecast
CHAPTER 5:BONE REPLACEMENT MARKET, BY MATERIAL
5.1.Overview
5.1.1.Market size and forecast
5.2.Allografts
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Autografts
5.3.1.Market size and forecast
5.3.2.Market analysis, by country
5.4.Synthetic materials
5.4.1.Market size and forecast
5.4.2.Market analysis, by country
5.5.Bone morphogenic proteins (BMPs)
5.5.1.Market size and forecast
5.5.2.Market analysis, by country
CHAPTER 6:BONE REPLACEMENT MARKET, BY AGE GROUP
6.1.Overview
6.1.1.Market size and forecast
6.2.<45 years
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.45-64 years
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.65 + years
6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country
CHAPTER 7:BONE REPLACEMENT MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country
7.2.2.1.U.S.
7.2.2.2.U.S. bone replacement market, by product type
7.2.2.3.U.S. bone replacement market, by material
7.2.2.4.U.S. bone replacement market, by age group
7.2.2.5.Canada bone replacement market
7.2.2.6.Canada bone replacement market, by product type
7.2.2.7.Canada bone replacement market, by material
7.2.2.8.Canada bone replacement market, by age group
7.2.2.9.Mexico bone replacement market
7.2.2.10.Mexico bone replacement market, by product type
7.2.2.11.Mexico bone replacement market, by material
7.2.2.12.Mexico bone replacement market, by age group
7.2.3.North America market size and forecast, by product type
7.2.4.North America market size and forecast, by material
7.2.5.North America market size and forecast, by age group
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country
7.3.2.1.Germany bone replacement market
7.3.2.2.Germany bone replacement market, by product type
7.3.2.3.Germany bone replacement market, by material
7.3.2.4.Germany bone replacement market, by age group
7.3.2.5.France bone replacement market, by product type
7.3.2.6.France bone replacement market, by product type
7.3.2.7.France bone replacement market, by material
7.3.2.8.France bone replacement market, by age group
7.3.2.9.UK bone replacement market
7.3.2.10.UK bone replacement market, by product type
7.3.2.11.UK bone replacement market, by material
7.3.2.12.UK bone replacement market, by age group
7.3.2.13.Italy bone replacement market
7.3.2.14.Italy bone replacement market, by product type
7.3.2.15.Italy bone replacement market, by material
7.3.2.16.Italy bone replacement market, by age group
7.3.2.17.Spain bone replacement market
7.3.2.18.Spain bone replacement market, by product type
7.3.2.19.Spain bone replacement market, by material
7.3.2.20.Spain bone replacement market, by age group
7.3.2.21.Rest of Europe bone replacement market, by product type
7.3.2.22.Rest of Europe bone replacement market, by product type
7.3.2.23.Rest of Europe bone replacement market, by material
7.3.2.24.Rest of Europe bone replacement market, by age group
7.3.3.Europe market size and forecast, by product type
7.3.4.Europe market size and forecast, by material
7.3.5.Europe market size and forecast, by age group
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country
7.4.2.1.Japan bone replacement market
7.4.2.2.Japan bone replacement market, by product type
7.4.2.3.Japan bone replacement market, by material
7.4.2.4.Japan bone replacement market, by age group
7.4.2.5.China bone replacement market
7.4.2.6.China bone replacement market, by product type
7.4.2.7.China bone replacement market, by material
7.4.2.8.China bone replacement market, by age group
7.4.2.9.Australia bone replacement market
7.4.2.10.Australia bone replacement market, by product type
7.4.2.11.Australia bone replacement market, by material
7.4.2.12.Australia bone replacement market, by age group
7.4.2.13.India bone replacement market
7.4.2.14.India bone replacement market, by product type
7.4.2.15.India bone replacement market, by material
7.4.2.16.India bone replacement market, by age group
7.4.2.17.South Korea bone replacement market
7.4.2.18.South Korea bone replacement market, by product type
7.4.2.19.South Korea bone replacement market, by material
7.4.2.20.South Korea bone replacement market, by age group
7.4.2.21.Rest of Asia-Pacific bone replacement market
7.4.2.22.Rest of Asia-Pacific bone replacement market, by product type
7.4.2.23.Rest of Asia-Pacific bone replacement market, by material
7.4.2.24.Rest of Asia-Pacific bone replacement market, by age group
7.4.3.Asia-Pacific market size and forecast, by product type
7.4.4.Asia-Pacific market size and forecast, by material
7.4.5.Asia-Pacific market size and forecast, by age group
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country
7.5.2.1.Brazil bone replacement market
7.5.2.2.Brazil bone replacement market, by product type
7.5.2.3.Brazil bone replacement market, by material
7.5.2.4.Brazil bone replacement market, by age group
7.5.2.5.Saudi Arabia bone replacement market
7.5.2.6.Saudi Arabia bone replacement market, by product type
7.5.2.7.Saudi Arabia bone replacement market, by material
7.5.2.8.Saudi Arabia bone replacement market, by age group
7.5.2.9.South Africa bone replacement market
7.5.2.10.South Africa bone replacement market, by product type
7.5.2.11.South Africa bone replacement market, by material
7.5.2.12.South Africa bone replacement market, by age group
7.5.2.13.Rest of LAMEA bone replacement market
7.5.2.14.Rest of LAMEA bone replacement market, by product type
7.5.2.15.Rest of LAMEA bone replacement market, by material
7.5.2.16.Rest of LAMEA bone replacement market, by age group
7.5.3.LAMEA market size and forecast, by product type
7.5.4.LAMEA market size and forecast, by material
7.5.5.LAMEA market size and forecast, by age group
CHAPTER 8:COMPANY PROFILES
8.1.B. BRAUN MELSUNGEN
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.2.AK MEDICAL HOLDINGS LIMITED (AK Medical)
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments
8.3.COLFAX CORPORATION (DJO Global, Inc.)
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.JOHNSON & JOHNSON (DePuy Synthes)
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product Portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments
8.5.SMITH & NEPHEW PLC
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.WALDEMAR LINK GMBH & CO. KG
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.7.EXACTECH INC
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Key strategic moves and developments
8.8.UNITED ORTHOPEDIC CORPORATION
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Key strategic moves and developments
8.9.STRYKER CORPORATION
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments
8.10.ZIMMER BIOMET HOLDINGS, INC.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
TABLE 01.GLOBAL BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 02.BONE REPLACEMENT MARKET FOR HIP, BY REGION, 2020-2030 ($MILLION)
TABLE 03.HIP MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 04.KNEE MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 05.KNEE MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 06.EXTREMITIES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 07.EXTREMITIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 08.BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030($MILLION)
TABLE 09.ALLOGRAFTS MARKET, BY REGION, 2020-2030($MILLION)
TABLE 10.AUTOGRAFT MARKET, BY REGION, 2020-2030($MILLION)
TABLE 11.SYNTHETIC MATERIALS MARKET, BY REGION, 2020-2030($MILLION)
TABLE 12.BONE MORPHOGENIC PROTEINS (BMPS) MARKET, BY REGION, 2020-2030($MILLION)
TABLE 13.BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030($MILLION)
TABLE 14.<45 YEARS MARKET, BY REGION, 2020-2030($MILLION)
TABLE 15.45-64 YEARS MARKET, BY REGION, 2020-2030($MILLION)
TABLE 16.65 + YEARS MARKET, BY REGION, 2020-2030($MILLION)
TABLE 17.BONE REPLACEMENT MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 18.NORTH AMERICA BONE REPLACEMENT MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 19.U.S. BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 20.U.S. BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 21.U.S. BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 22.CANADA BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 23.CANADA BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 24.CANADA BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 25.MEXICO BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 26.MEXICO BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 27.MEXICO BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 28.NORTH AMERICA BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 29.NORTH AMERICA BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 30.NORTH AMERICA BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 31.EUROPE BONE REPLACEMENT MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 32.GERMANY BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 33.GERMANY BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 34.GERMANY BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 35.FRANCE BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 36.FRANCE BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 37.FRANCE BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 38.UK BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 39.UK BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 40.UK BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 41.ITALY BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 42.ITALY BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 43.ITALY BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 44.SPAIN BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 45.SPAIN BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 46.SPAIN BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 47.REST OF EUROPE BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 48.REST OF EUROPE BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 49.REST OF EUROPE BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 50.EUROPE BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 51.EUROPE BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 52.EUROPE BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 53.ASIA-PACIFIC BONE REPLACEMENT MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 54.JAPAN BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 55.JAPAN BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 56.JAPAN BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 57.CHINA BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 58.CHINA BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 59.LAMEA BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 60.AUSTRALIA BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 61.AUSTRALIA BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 62.AUSTRALIA BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 63.INDIA BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 64.INDIA BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 65.INDIA BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 66.SOUTH KOREA BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 67.SOUTH KOREA BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 68.SOUTH KOREA BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 69.REST OF ASIA-PACIFIC BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 70.REST OF ASIA-PACIFIC BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 71.REST OF ASIA-PACIFIC BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 72.ASIA-PACIFIC BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 73.ASIA-PACIFIC BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 74.ASIA-PACIFIC BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 75.LAMEA BONE REPLACEMENT MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 76.BRAZIL BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 77.BRAZIL BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 78.BRAZIL BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 79.SAUDI ARABIA BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 80.SAUDI ARABIA BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 81.SAUDI ARABIA BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 82.SOUTH AFRICA BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 83.SOUTH AFRICA BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 84.SOUTH AFRICA BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 85.REST OF LAMEA BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 86.REST OF LAMEA BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 87.LAMEA BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 88.LAMEA BONE REPLACEMENT MARKET, BY PRODUCT TYPE, 2020-2030
TABLE 89.LAMEA BONE REPLACEMENT MARKET, BY MATERIAL, 2020-2030
TABLE 90.LAMEA BONE REPLACEMENT MARKET, BY AGE GROUP, 2020-2030
TABLE 91.B BRAUN: COMPANY SNAPSHOT
TABLE 92.B BRAUN: OPERATING SEGMENTS
TABLE 93.B BRAUN: PRODUCT PORTFOLIO
TABLE 94.AK MEDICAL: COMPANY SNAPSHOT
TABLE 95.AK MEDICAL: OPERATING SEGMENTS
TABLE 96.AK MEDICAL: PRODUCT PORTFOLIO
TABLE 97.COLFAX: COMPANY SNAPSHOT
TABLE 98.COLFAX: OPERATING SEGMENTS
TABLE 99.COLFAX: PRODUCT PORTFOLIO
TABLE 100.J&J: COMPANY SNAPSHOT
TABLE 101.J&J: OPERATING SEGMENTS
TABLE 102.J&J: PRODUCT PORTFOLIO
TABLE 103.J&J: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 104.SMITH & NEPHEW: COMPANY SNAPSHOT
TABLE 105.SMITH & NEPHEW: OPERATING SEGMENTS
TABLE 106.SMITH & NEPHEW: PRODUCT PORTFOLIO
TABLE 107.WALDEMAR LINK: COMPANY SNAPSHOT
TABLE 108.WALDEMAR LINK: PRODUCT PORTFOLIO
TABLE 109.EXACTECH: COMPANY SNAPSHOT
TABLE 110.EXACTECH: PRODUCT PORTFOLIO
TABLE 111.EXACTECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 112.UNITED ORTHOPEDIC: COMPANY SNAPSHOT
TABLE 113.UNITED ORTHOPEDIC: PRODUCT PORTFOLIO
TABLE 114.UNITED ORTHOPEDIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 115.STRYKER: COMPANY SNAPSHOT
TABLE 116.STRYKER: OPERATING SEGMENTS
TABLE 117.STRYKER: PRODUCT PORTFOLIO
TABLE 118.STRYKER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 119.ZIMMER BIOMET: COMPANY SNAPSHOT
TABLE 120.ZIMMER BIOMET: OPERATING SEGMENTS
TABLE 121.ZIMMER BIOMET: PRODUCT PORTFOLIO
Similar Reports
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
- Publish Date: September 1, 2016
- $5370
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
- Publish Date: May 24, 2017
- $5370
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...
- Publish Date: May 24, 2017
- $5370
